Provided by Tiger Trade Technology Pte. Ltd.

Progress

43.33
-1.8900-4.18%
Post-market: 43.330.00000.00%19:30 EDT
Volume:868.13K
Turnover:38.19M
Market Cap:1.78B
PE:20.93
High:45.80
Open:45.22
Low:43.23
Close:45.22
52wk High:47.37
52wk Low:23.82
Shares:41.01M
Float Shares:40.11M
Volume Ratio:1.52
T/O Rate:2.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.07
EPS(LYR):1.66
ROE:18.57%
ROA:4.89%
PB:3.51
PE(LYR):26.10

Loading ...

Essential Utilities Updates Progress on American Water Merger

TIPRANKS
·
Aug 18

Petco Health & Wellness' Q2 Results to Illustrate Progress on Return-to-Growth Initiatives, RBC Says

MT Newswires Live
·
Aug 17

20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level

GlobeNewswire
·
Aug 17

Plus500's Valuation Doesn't Reflect Recent Strategic Progress

Dow Jones
·
Aug 17

Oil Prices Retain Risk Premium as Iran, Oman Progress Talks on Strait of Hormuz

Dow Jones
·
Aug 17

Press Release: Valerio Therapeutics and Etherna Immunotherapies Progress Towards Finalisation of Transaction Documentation Regarding the Contemplated Acquisition

Dow Jones
·
Aug 17

Perrigo Earnings Call Balances Pressure and Progress

TIPRANKS
·
Aug 17

Mirrabooka Updates Market on Progress of On‑Market Share Buy‑Back

TIPRANKS
·
Aug 17

Dexus Industria REIT Updates Market on Progress of On-Market Buy-Back

TIPRANKS
·
Aug 17

Andromeda Metals Launches $3m Share Purchase Plan to Progress High Purity Alumina Project

TIPRANKS
·
Aug 17

SGH Limited Updates Market on Progress of Ongoing Share Buy-Back

TIPRANKS
·
Aug 17

Tian An Medicare (SEHK:383) Stock Trails Revenue Progress With Margin Squeeze

Simply Wall St.
·
Aug 16

Urban One Earnings Call Balances Progress and Pressure

TIPRANKS
·
Aug 16

Analyst Reiterates Buy on ProMIS Neurosciences, Maintaining $35 Price Target Amid Strong Cash Position and PMN310 Clinical Progress

TIPRANKS
·
Aug 15

Moleculin: Buy Rating Maintained as MIRACLE Trial Progress Offsets Dilution; McCarthy Trims Price Target After Equity Financing

TIPRANKS
·
Aug 15

Northwest Healthcare Properties Earnings Call Signals Progress

TIPRANKS
·
Aug 15

Western Forest Products Balances Progress With Tariff Pain

TIPRANKS
·
Aug 15

CAMP4 Analyst Day, Strong Cash Runway and SYNGAP1 Trial Progress Drive Upward Price-Target Revision to $8 with Buy Rating

TIPRANKS
·
Aug 15

DarkIris Inc. Updates Strategic and Operational Progress on AI Initiatives and Gaming Business

GlobeNewswire
·
Aug 15

Intellia Therapeutics: Buy Rating Reiterated as Clinical Progress and Risk Management Support Unchanged $29 Price Target

TIPRANKS
·
Aug 15